They do a zillion different things, and, like some of the tiny blades on that Swiss army knife, its not entirely clear how some of these things actually work
Beyond obesity, retatrutide is being investigated for type 2 diabetes and metabolic dysfunction-associated steatohepatitis (MASH), conditions where the combination of weight loss, improved glycemic control, and enhanced hepatic fat oxidation could provide comprehensive therapeutic benefits
Eur J Endocrinol (2011) 165:38392
It is a dual GIP and GLP-1 receptor agonist, meaning it activates two incretin hormone pathways simultaneously
So many bodily fluids, so little time
Its possible that the combination of semaglutide with another drug could be leading to cramps